| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.08 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.095 | 0.08 |